Amylyx class action Relyvrio, page-51

12 Patients, upto 18 months now, still swallowing, all enrolled for extension study, where is the one in 12? ….,not There, where is the one in 24?…..we don’t know yet. My gut feeling is if 12 phase 1ers ……have all defied the odds by 1000…..so far….i don’t see it being a setback in future with 120 or 210. Unless of course Monepantel is not crossing the blood brain barrier, 100% extremely well tolerated, 100% participants choose to stay on extended study…….when and where we find one that fails……..long shot in my Opinion, maybe 48:1. Next 102:1…….Still get my Drift, So Far……Outstanding!! And if High dose from the start of phase 2/3…….this could cost us a Fortune, on extended compassionate Grouds, we need a partner to step IN.